Editorial: The Effects of Vibratory Therapy on Endocrine Disorders
Clinical Scorecard: The Effects of Vibratory Therapy on Endocrine Disorders
At a Glance
Category Detail
Condition Endocrine disorders (e.g., osteoporosis, obesity, diabetes) Key Mechanisms Mechanical vibration stimulates mechanoreceptors, promoting hormone release and enhancing bone and metabolic health. Target Population Individuals with osteoporosis, obesity, diabetes, and related endocrine disorders. Care Setting Clinical settings, including multidisciplinary body weight reduction programs.
Key Highlights
Vibratory therapy (VT) may improve bone mineral density and reduce fracture risk. SVT shows potential as a non-pharmacological intervention for endocrine disorders. VT combined with active muscle contractions enhances biological effects. Research indicates VT can increase resting energy expenditure in obese adolescents. VT may regulate bone metabolism and support osteoporosis management. Guideline-Based Recommendations
Diagnosis
Consider endocrine assessments in patients with osteoporosis, obesity, and diabetes. Management
Incorporate vibratory therapy as a complementary strategy in managing osteoporosis. Monitoring & Follow-up
Monitor bone density and metabolic parameters in patients undergoing VT. Risks
Passive vibratory stimulation alone may not provide optimal therapeutic effects. Patient & Prescribing Data
Patients with osteoporosis, obesity, and diabetes, particularly those with limited exercise tolerance.
VT may offer metabolic and functional benefits when combined with structured physical exercise.
Clinical Best Practices
Utilize VT in conjunction with pharmacological treatments for osteoporosis. Encourage active muscle contractions during VT for enhanced outcomes. Implement VT in multidisciplinary programs for weight reduction and metabolic health. Related Resources & Content
